Article Information
History
- January 31, 2023.
Article Versions
- Version 1 (January 22, 2023 - 19:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tianyang Yan1,2,
- Ashley R. Julio1,2,
- Miranda Villanueva1,4,
- Anthony E. Jones3,
- Andréa B. Ball3,
- Lisa M. Boatner1,2,
- Alexandra C. Turmon1,2,
- Stephanie L. Yen1,
- Heta S. Desai1,4,
- Ajit S. Divakaruni3 and
- Keriann M. Backus1,2,4,5,6,7,*
- 1Biological Chemistry Department, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA
- 2Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, 90095, USA
- 3Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA
- 4Molecular Biology Institute, UCLA, Los Angeles, CA, 90095, USA
- 5DOE Institute for Genomics and Proteomics, UCLA, Los Angeles, CA, 90095, USA
- 6Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, 90095, USA
- 7Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, UCLA, Los Angeles, CA, 90095, USA
- ↵*Corresponding Author: Keriann M. Backus, Biological Chemistry Department, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA, E-mail: kbackus{at}mednet.ucla.edu.
Posted January 31, 2023.
Proximity-labeling chemoproteomics defines the subcellular cysteinome and inflammation-responsive mitochondrial redoxome
